# Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Article · Deepak L. Bhatt, Philippe Gabríel Steg, Michael J. Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Craig B. Granowitz, Jean‐Claude Tardif, Christie Mitchell Ballantyne

- Archive id: doi:10.1056/nejmoa1812792
- Published: 2018-11-10
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa1812792
- PMID: 30415628
- Citations: 3,316
- Source URL: https://doi.org/10.1056/nejmoa1812792
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.